Algo version: 0.98b
MorphoSys AG is listed at the SIX Exchange
MorphoSys AG [MOR.SW]
SIX Sector: Healthcare Industry:Biotechnology

Is MorphoSys AG stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for MorphoSys AG 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was CHF102.00, you would have made a loss of CHF0.000 per share or 0.00%

We do not have enough data to give you this answer.

MorphoSys AG has much of the business financed by loans. This puts the company at high risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for MorphoSys AG to be high [1 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.